Stage IIIB Skin Melanoma Completed Phase 3 Trials for Teceleukin (DB15389)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0029534 (Stage IIIB Skin Melanoma) | Completed | 3 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT00019682 | Aldesleukin With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Melanoma | Treatment |